Email Updates

You are here

Home

Benin Demonstration Project

Status
Ongoing
Phase
Demo Project
Principal Investigator(s)
CHU de Quebec
Objective

To assess the feasibility and usefulness of integrating TasP and PrEP to the combination prevention package offered to FSWs in Benin, to identify, if proven feasible  and useful, the best way to successfully implement TasP and PrEP in this specific setting and to ensure their adoption by national policymakers as part of the HIV prevention package for FSWs.

Prevention Option(s)
PrEP
Study Design
Non-randomized
Open label
Arms and Assigned Interventions
Description
In early October first participants were enrolled and receiving PrEP
Mode of Delivery
Tablet
Products
TDF/FTC (Truvada)
ARMs
Experimental
Official Code
NCT02237027
Trial Sponsors
CHU de Quebec
Product Developers
Gilead Sciences
October 2014
January 2017
Enrollment
350
18
Years
Population
Women
Sites

Dispensaire IST (DIST)

Benin